483 Regenesis Pharmaceutical Jun 2019

483 Regenesis Pharmaceutical Jun 2019

Alan Truong FDA$119.00 - Available Now

FDA investigators audited the Regenesis Pharmaceutical - Santa Ana, CA, United States facility and issued inspectional observations (via FDA 483) on 18 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Jun 2019
  • Location: Santa Ana, United States
  • FEI: 3015180086
Add To Cart